1. Home
  2. ALAR vs MGTX Comparison

ALAR vs MGTX Comparison

Compare ALAR & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alarum Technologies Ltd.

ALAR

Alarum Technologies Ltd.

HOLD

Current Price

$1.82

Market Cap

13.3M

Sector

Technology

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$10.96

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALAR
MGTX
Founded
2013
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3M
1.1B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
ALAR
MGTX
Price
$1.82
$10.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$14.00
★ $24.57
AVG Volume (30 Days)
167.8K
★ 824.2K
Earning Date
05-28-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.02
EPS
N/A
★ 1.30
Revenue
N/A
★ $81,391,000.00
Revenue This Year
$24.51
$141.38
Revenue Next Year
$33.43
N/A
P/E Ratio
$44.31
★ $8.50
Revenue Growth
N/A
★ 144.57
52 Week Low
$1.16
$6.62
52 Week High
$16.56
$15.35

Technical Indicators

Market Signals
Indicator
ALAR
MGTX
Relative Strength Index (RSI) 44.40 26.47
Support Level $1.62 $8.84
Resistance Level $2.10 $11.85
Average True Range (ATR) 0.21 0.56
MACD 0.02 -0.28
Stochastic Oscillator 32.00 9.42

Price Performance

Historical Comparison
ALAR
MGTX

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment: web data collection. Geographically, it derives maximum revenue from China, followed by the United States, Europe, Hong Kong, Asia-Pacific, U.K. Virgin Islands, Israel, United Arab Emirates, Middle East & Africa and other.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: